George Atiee, M.D., to discuss clinical trial preparation, team selection, and issue handling from a principal investigator’s perspective
MORRISVILLE, NC, FEBRUARY 13, 2017 – George Atiee, M.D., Medical Director and Principal Investigator at Worldwide Clinical Trials Early Phase Services (www.worldwide.com), will present at the annual Outsourcing in Clinical Trials West Coast (OCT-WC) conference, being held February 22-23, 2017, in Burlingame, Calif. Dr. Atiee, who has 20 years of experience in both early and late phase drug development, will present his recommendations and best practices for principal investigators in ensuring successful study conduct on Wednesday, February 22 at 4:40 p.m. PT. “The time, cost and ultimately the success of a clinical trial can be influenced by a number of factors, which is why it is essential to optimize protocols to ensure fluidity and efficiency,” explains Dr. Atiee. “I will discuss defining where to start, sourcing your team, meeting requirements – just a few of the factors that if not properly addressed, could make or break a study.”
In addition to Dr. Atiee’s presentation, experts from the Worldwide Clinical Trials team will be available at booth #17 throughout OCT-WC to discuss the individual drug development challenges of attendees, as well as their needs across a range of therapeutic areas, including central nervous system disorders, cardiovascular disease, inflammatory disorders, and rare diseases.
OCT-WC offers two days of interactive sessions focused on clinical outsourcing strategies and overcoming key challenges within clinical operations. For further information, visit www.arena-international.com/octwestcoast/.
Connect with Worldwide Clinical Trials:
• Tweet: @worldwidetrials Dr. Atiee to Present at Outsourcing in Clinical Trials West Coast 2017
• Follow us on Twitter: @worldwidetrials
• Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit worldwide.com.
